Several other purine analogs have been studied on MTAP-deleted tumors, including 6-thioguanine that targets de novo purine synthesis and kills tumor cells by incorporating 6-thioguanine nucleotides into DNA [155,156,157]. Here, MTAP is linked to neoplasm.